packageEnvafolimab

envafolimab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Envafolimab is an investigational anticancer monoclonal antibody that blocks the PD-1/PD-L1 pathway. It is not yet an approved medicine and remains under investigation, with no marketing authorisation in the European Union.

Summary written by glm-5.3-flash from Wikidata Q123499516 and the WHO ATC classification; not checked by a person.

name:envafolimab
ATC codes:L01FF15
DrugBank:DB15769
Wikidata:Q123499516

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown